Page last updated: 2024-08-24

fluorodopa f 18 and Disease Exacerbation

fluorodopa f 18 has been researched along with Disease Exacerbation in 30 studies

Research

Studies (30)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (16.67)	18.2507
2000's	14 (46.67)	29.6817
2010's	11 (36.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arcolin, M; Bertoldo, A; Dipasquale, O; Expert, P; Fisher, PM; Howes, O; Khan, W; Moro, L; Rizzo, G; Svarer, C; Turkheimer, FE; Veronese, M	1
Allen-Auerbach, M; Chen, W; Czernin, J; DeSalles, AA; Lizarraga, KJ; Phelps, ME; Yong, WH	1
Cabria, M; Cama, A; Garrè, ML; Milanaccio, C; Morana, G; Nozza, P; Piccardo, A; Puntoni, M; Rossi, A; Zefiro, D	1
Bendlin, BB; Buyan-Dent, L; Christian, BT; DeJesus, OT; Gallagher, CL; Harding, SJ; Holden, JE; Li, CT; Nickles, RJ; Oh, J; Okonkwo, O; Palotti, M; Stone, CK	1
Chen, W; De Salles, AA; Lizarraga, KJ	1
Benisvy, D; Darcourt, J; Dufour, M; Fontana, X; Koulibaly, PM; Ouvrier, MJ; Sapin, N; Schiazza, A	1
Buck, AK; Dralle, H; Glatting, G; Karges, W; Luster, M; Mottaghy, FM; Neumaier, B; Pauls, S; Reske, SN; Solbach, C; Verburg, FA; Zeich, K	1
Schwarz, J	1
Goldstein, DS; Holmes, C; Park, MY; Sewell, L; Sharabi, Y	1
Allen, P; Broome, M; Egerton, A; Fusar-Poli, P; Hirao, K; Howes, OD; Kambeitz, J; Luigjes, J; McGuire, P; Valli, I	1
Brouwers, AH; de Groot, JW; Hofstra, RM; Koopmans, KP; Links, TP; Muller Kobold, AC; Plukker, JT; van der Horst-Schrivers, AN; Verbeek, HH	1
Jennings, D; Marek, K; Seibyl, J	1
Bailey, DL; Brooks, DJ; Ito, K; Morrish, PK; Pavese, N; Rakshi, JS; Uema, T	1
Brooks, DJ; Frey, KA; Marek, KL; Oakes, D; Paty, D; Prentice, R; Shults, CW; Stoessl, AJ	1
Heiss, WD; Hilker, R	1
de la Fuente-Fernández, R; Holden, JE; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, J	1
Coburger, S; Ghaemi, M; Heiss, WD; Herholz, K; Hilker, R; Jacobs, AH; Rudolf, J; Schweitzer, K; Weisenbach, S	1
Borghammer, P; Cumming, P; Kumakura, Y	1
Lilien, DL; Patterson, J; Tainter, K; Zweig, RM	1
Aalto, S; Bergman, J; Brück, A; Nurmi, E; Rinne, JO; Vahlberg, T	1
Ahsan, RL; Brooks, DJ; de Yébenes, JG; Pavese, N; Piccini, P; Tai, YF	1
Barlier, A; Colavolpe, C; De Micco, C; Henry, JF; Morange, I; Mundler, O; Niccoli-Sire, P; Palazzo, FF; Sebag, F; Taïeb, D; Tessonnier, L	1
Calne, DB; Lee, CS; Mak, E; Schulzer, M; Snow, BJ; Vingerhoets, FJ	1
Calne, DB; Langston, JW; Schulzer, M; Snow, BJ; Tetrud, JW; Vingerhoets, FJ	1
Brooks, DJ; Morrish, PK; Sawle, GV	1
Bailey, DL; Brooks, DJ; Morrish, PK; Rakshi, JS; Sawle, GV	1
Poewe, WH; Wenning, GK	1
Bergman, J; Brück, A; Eskola, O; Kaasinen, V; Nurmi, E; Rinne, JO; Solin, O	1
Bergman, J; Haaparanta, M; Nurmi, E; Rinne, JO; Ruottinen, HM; Solin, O; Sonninen, P	1
Jankovic, J; Kapadia, AS	1

Reviews

6 review(s) available for fluorodopa f 18 and Disease Exacerbation

Article	Year
18F-FDOPA PET for the diagnosis of parkinsonian syndromes. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2014, Volume: 58, Issue:4 Topics: Brain; Dihydroxyphenylalanine; Disease Progression; Humans; Image Processing, Computer-Assisted; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors	2014
[Nuclear medicine imaging in patients with Parkinson's syndrome: an update]. Der Nervenarzt, 2010, Volume: 81, Issue:10 Topics: Animals; Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Energy Metabolism; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Nerve Degeneration; Neurons; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Receptors, Dopamine; Regional Blood Flow; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	2010
Do dopamine agonists or levodopa modify Parkinson's disease progression? European journal of neurology, 2002, Volume: 9 Suppl 3 Topics: Animals; Antiparkinson Agents; Benzothiazoles; Carrier Proteins; Dihydroxyphenylalanine; Disease Progression; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Humans; Indoles; Iodine Radioisotopes; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Neostriatum; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Radiopharmaceuticals; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tropanes	2002
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease. Experimental neurology, 2003, Volume: 184 Suppl 1 Topics: Animals; Basal Ganglia; Biomarkers; Cocaine; Diagnostic Imaging; Dihydroxyphenylalanine; Disease Progression; Dopamine Plasma Membrane Transport Proteins; Humans; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuropeptides; Parkinson Disease; Radiopharmaceuticals; Technology Assessment, Biomedical; Tetrabenazine; Tomography, Emission-Computed, Single-Photon; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2003
The sensitivity of 18-fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease. European journal of neurology, 2004, Volume: 11, Issue:1 Topics: Brain; Diagnosis, Differential; Dihydroxyphenylalanine; Disease Progression; Humans; Magnetic Resonance Imaging; Parkinson Disease; Sensitivity and Specificity; Tomography, Emission-Computed	2004
The natural history of Parkinson's disease. Annals of neurology, 1998, Volume: 44, Issue:3 Suppl 1 Topics: Cell Count; Dihydroxyphenylalanine; Disabled Persons; Disease Progression; Fluorine Radioisotopes; Humans; Parkinson Disease; Risk Factors; Substantia Nigra	1998

Trials

2 trial(s) available for fluorodopa f 18 and Disease Exacerbation

Article	Year
A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18F-dopa PET study. Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:12 Topics: Aged; Antiparkinson Agents; Dihydroxyphenylalanine; Disease Progression; Fluorine Radioisotopes; Follow-Up Studies; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Tomography, Emission-Computed	2002
The rate of progression of Parkinson's disease. A longitudinal [18F]DOPA PET study. Advances in neurology, 1996, Volume: 69 Topics: Aged; Aging; Caudate Nucleus; Dihydroxyphenylalanine; Disease Progression; Humans; Longitudinal Studies; Middle Aged; Neostriatum; Parkinson Disease; Putamen; Tomography, Emission-Computed	1996

Article

Year

A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18F-dopa PET study.

Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:12

Topics: Aged; Antiparkinson Agents; Dihydroxyphenylalanine; Disease Progression; Fluorine Radioisotopes; Follow-Up Studies; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Tomography, Emission-Computed

2002

The rate of progression of Parkinson's disease. A longitudinal [18F]DOPA PET study.

Advances in neurology, 1996, Volume: 69

Topics: Aged; Aging; Caudate Nucleus; Dihydroxyphenylalanine; Disease Progression; Humans; Longitudinal Studies; Middle Aged; Neostriatum; Parkinson Disease; Putamen; Tomography, Emission-Computed

1996

Other Studies

22 other study(ies) available for fluorodopa f 18 and Disease Exacerbation

Article	Year
Covariance statistics and network analysis of brain PET imaging studies. Scientific reports, 2019, 02-21, Volume: 9, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cross-Sectional Studies; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroimaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals	2019
(18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:1 Topics: Adult; Aged; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiation Injuries; Radiotherapy; Recurrence; Sensitivity and Specificity; Young Adult	2014
Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:5 Topics: Adolescent; Astrocytoma; Biomarkers; Brain; Brain Neoplasms; Child; Dihydroxyphenylalanine; Disease Progression; Disease-Free Survival; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Pilot Projects; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Treatment Outcome	2014
A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa uptake in Parkinson's disease. Synapse (New York, N.Y.), 2014, Volume: 68, Issue:8 Topics: Brain; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Tyrosine	2014
¹⁸F-fluorodopa positron-emission tomography: an emerging imaging modality for patients with brain metastases. Expert review of medical devices, 2014, Volume: 11, Issue:4 Topics: Biopsy; Brain Neoplasms; Dihydroxyphenylalanine; Disease Progression; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries	2014
Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma. Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:5 Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Medullary; Child; Dihydroxyphenylalanine; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Thyroid Neoplasms; Young Adult	2010
Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy. Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2012, Volume: 22, Issue:1 Topics: Aged; alpha-Synuclein; Autonomic Denervation; Dementia; Dihydroxyphenylalanine; Disease Progression; Dopamine; Dopaminergic Neurons; Gait Disorders, Neurologic; Hallucinations; Humans; Lewy Body Disease; Male; Neostriatum; Norepinephrine; Parkinson Disease; Radiopharmaceuticals; Shy-Drager Syndrome; Sympathetic Nervous System	2012
Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals. Schizophrenia bulletin, 2012, Volume: 38, Issue:6 Topics: Adult; Brain; Brain Mapping; Case-Control Studies; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Functional Neuroimaging; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mesencephalon; Pons; Positron-Emission Tomography; Prefrontal Cortex; Prodromal Symptoms; Psychotic Disorders; Radiopharmaceuticals; Risk; Speech Production Measurement	2012
Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:12 Topics: Adult; Aged; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Survival Analysis; Thyroid Neoplasms; Young Adult	2012
Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2004, Volume: 24, Issue:8 Topics: Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed	2004
Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Archives of neurology, 2005, Volume: 62, Issue:3 Topics: Adult; Aged; Cohort Studies; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Female; Fluorine Radioisotopes; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Nonlinear Dynamics; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Statistics, Nonparametric	2005
Fluorodopa F 18 positron emission tomography and the progression of Parkinson disease. Archives of neurology, 2005, Volume: 62, Issue:9 Topics: Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Humans; Linear Models; Parkinson Disease; Positron-Emission Tomography; Tomography, Emission-Computed	2005
The role of radiotracer imaging in Parkinson disease. Neurology, 2005, Oct-11, Volume: 65, Issue:7 Topics: Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Parkinson Disease; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Tomography, Emission-Computed, Single-Photon	2005
Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:7 Topics: Aged; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Dominance, Cerebral; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; Reference Values	2006
Characterization of dopaminergic dysfunction in familial progressive supranuclear palsy: an 18F-dopa PET study. Journal of neural transmission (Vienna, Austria : 1996), 2007, Volume: 114, Issue:3 Topics: Aged; Amygdala; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Dopamine; Down-Regulation; Female; Genetic Predisposition to Disease; Humans; Limbic System; Male; Neurocognitive Disorders; Pedigree; Positron-Emission Tomography; Predictive Value of Tests; Reference Values; Supranuclear Palsy, Progressive	2007
The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas. Clinical endocrinology, 2008, Volume: 69, Issue:4 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Tomography, Emission-Computed, Single-Photon	2008
Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Annals of neurology, 1994, Volume: 36, Issue:5 Topics: Adult; Aged; Dihydroxyphenylalanine; Disease Progression; Female; Humans; Male; Middle Aged; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed	1994
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Annals of neurology, 1994, Volume: 36, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Aged; Aged, 80 and over; Corpus Striatum; Dihydroxyphenylalanine; Disease Progression; Dopamine; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Substantia Nigra; Syndrome; Tomography, Emission-Computed	1994
Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET. Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 64, Issue:3 Topics: Aged; Case-Control Studies; Caudate Nucleus; Dihydroxyphenylalanine; Disease Progression; Humans; Linear Models; Middle Aged; Parkinson Disease; Prospective Studies; Putamen; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed	1998
Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex. Brain : a journal of neurology, 2001, Volume: 124, Issue:Pt 6 Topics: Aged; Dihydroxyphenylalanine; Disease Progression; Dopamine; Female; Functional Laterality; Humans; Male; Middle Aged; Neostriatum; Neurons; Parkinson Disease; Prefrontal Cortex; Sex Characteristics	2001
Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study. Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:4 Topics: Adult; Aged; Caudate Nucleus; Dihydroxyphenylalanine; Disease Progression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed	2001
Functional decline in Parkinson disease. Archives of neurology, 2001, Volume: 58, Issue:10 Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Demography; Dihydroxyphenylalanine; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multiple System Atrophy; Multivariate Analysis; Neurologic Examination; Parkinson Disease; Radiopharmaceuticals; Time Factors	2001